Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lipella Pharmaceuticals Inc

2.54
-0.0610-2.35%
Volume:9.10K
Turnover:23.07K
Market Cap:3.07M
PE:-0.57
High:2.60
Open:2.54
Low:2.45
Close:2.60
Loading ...

Company Profile

Company Name:
Lipella Pharmaceuticals Inc
Exchange:
NASDAQ
Establishment Date:
2005
Employees:
6
Office Location:
7800 Susquehanna St.,Suite 505,Pittsburgh,Pennsylvania,United States
Zip Code:
15208
Fax:
- -
Introduction:
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinical trial for patients with radiation-induced hemorrhagic cystitis; and LP-310, a formulation of tacrolimus for the treatment of oral lichen planus. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is based in Pittsburgh, Pennsylvania.

Directors

Name
Position
Jonathan Kaufman
President, Chief Executive Officer, Secretary, Treasurer and Chairman of the Board
Michael Chancellor
Chief Medical Officer and Director
Byong Kim
Director
Daniel Cohen
Director
Lori Birder
Director
Naoki Yoshimura
Director
Ryan Pruchnic
Director

Shareholders

Name
Position
Jonathan Kaufman
President, Chief Executive Officer, Secretary, Treasurer and Chairman of the Board
Douglas Johnston
Chief Financial Officer
Michael Chancellor
Chief Medical Officer and Director